These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 28912442)
1. The association between respiratory tract infection incidence and localised meningitis epidemics: an analysis of high-resolution surveillance data from Burkina Faso. Mueller JE; Woringer M; Porgho S; Madec Y; Tall H; Martiny N; Bicaba BW Sci Rep; 2017 Sep; 7(1):11570. PubMed ID: 28912442 [TBL] [Abstract][Full Text] [Related]
2. Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data. Novak RT; Kambou JL; Diomandé FV; Tarbangdo TF; Ouédraogo-Traoré R; Sangaré L; Lingani C; Martin SW; Hatcher C; Mayer LW; Laforce FM; Avokey F; Djingarey MH; Messonnier NE; Tiendrébéogo SR; Clark TA Lancet Infect Dis; 2012 Oct; 12(10):757-64. PubMed ID: 22818241 [TBL] [Abstract][Full Text] [Related]
3. Atmospheric Dust, Early Cases, and Localized Meningitis Epidemics in the African Meningitis Belt: An Analysis Using High Spatial Resolution Data. Woringer M; Martiny N; Porgho S; Bicaba BW; Bar-Hen A; Mueller JE Environ Health Perspect; 2018 Sep; 126(9):97002. PubMed ID: 30192160 [TBL] [Abstract][Full Text] [Related]
4. Definition and characterization of localised meningitis epidemics in Burkina Faso: a longitudinal retrospective study. Tall H; Hugonnet S; Donnen P; Dramaix-Wilmet M; Kambou L; Drabo F; Mueller JE BMC Infect Dis; 2012 Jan; 12():2. PubMed ID: 22221583 [TBL] [Abstract][Full Text] [Related]
5. Emergence of serogroup X meningococcal disease in Africa: need for a vaccine. Xie O; Pollard AJ; Mueller JE; Norheim G Vaccine; 2013 Jun; 31(27):2852-61. PubMed ID: 23623866 [TBL] [Abstract][Full Text] [Related]
6. Conjugate vaccine introduction in the African meningitis belt: meeting surveillance objectives. Mueller JE Trop Med Int Health; 2013 Jan; 18(1):58-64. PubMed ID: 23121399 [TBL] [Abstract][Full Text] [Related]
7. High-spatial resolution epidemic surveillance of bacterial meningitis in the African meningitis belt in Burkina Faso. Woringer M; Porgho S; Fermanian C; Martiny N; Bar-Hen A; Mueller JE Sci Rep; 2022 Nov; 12(1):19451. PubMed ID: 36376459 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of meningitis surveillance before introduction of serogroup a meningococcal conjugate vaccine - Burkina Faso and Mali. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2012 Dec; 61(50):1025-8. PubMed ID: 23254257 [TBL] [Abstract][Full Text] [Related]
9. [Clonal expansion of Neisseria meningitidis W135. Epidemiological implications for the African meningitis belt]. du Châtelet IP; Alonso JM; Taha MK Bull Soc Pathol Exot; 2002 Dec; 95(5):323-4; discussion 324-5. PubMed ID: 12696368 [TBL] [Abstract][Full Text] [Related]
10. Association of respiratory tract infection symptoms and air humidity with meningococcal carriage in Burkina Faso. Mueller JE; Yaro S; Madec Y; Somda PK; Idohou RS; Lafourcade BM; Drabo A; Tarnagda Z; Sangaré L; Traoré Y; Fontanet A; Gessner BD Trop Med Int Health; 2008 Dec; 13(12):1543-52. PubMed ID: 18983283 [TBL] [Abstract][Full Text] [Related]
12. Meningitis epidemics in Africa: a brief overview. Teyssou R; Muros-Le Rouzic E Vaccine; 2007 Sep; 25 Suppl 1():A3-7. PubMed ID: 17643560 [TBL] [Abstract][Full Text] [Related]
13. Detection of meningitis epidemics in Africa: a population-based analysis. Moore PS; Plikaytis BD; Bolan GA; Oxtoby MJ; Yada A; Zoubga A; Reingold AL; Broome CV Int J Epidemiol; 1992 Feb; 21(1):155-62. PubMed ID: 1544747 [TBL] [Abstract][Full Text] [Related]
14. Impact of MenAfriVac in nine countries of the African meningitis belt, 2010-15: an analysis of surveillance data. Trotter CL; Lingani C; Fernandez K; Cooper LV; Bita A; Tevi-Benissan C; Ronveaux O; Préziosi MP; Stuart JM Lancet Infect Dis; 2017 Aug; 17(8):867-872. PubMed ID: 28545721 [TBL] [Abstract][Full Text] [Related]
15. [Meningococcal meningitis epidemics in sub-Saharan Africa and the meningococcal A conjugate vaccine]. Nicolas P Med Sante Trop; 2012; 22(3):246-58. PubMed ID: 23186941 [TBL] [Abstract][Full Text] [Related]
16. The outbreak of meningitis due to Neisseria meningitidis W135 in 2003 in Burkina Faso and the national response: main lessons learnt. Zombré S; Hacen MM; Ouango G; Sanou S; Adamou Y; Koumaré B; Kondé MK Vaccine; 2007 Sep; 25 Suppl 1():A69-71. PubMed ID: 17630052 [TBL] [Abstract][Full Text] [Related]
17. Effectively introducing a new meningococcal A conjugate vaccine in Africa: the Burkina Faso experience. Djingarey MH; Barry R; Bonkoungou M; Tiendrebeogo S; Sebgo R; Kandolo D; Lingani C; Preziosi MP; Zuber PL; Perea W; Hugonnet S; Dellepiane de Rey Tolve N; Tevi-Benissan C; Clark TA; Mayer LW; Novak R; Messonier NE; Berlier M; Toboe D; Nshimirimana D; Mihigo R; Aguado T; Diomandé F; Kristiansen PA; Caugant DA; Laforce FM Vaccine; 2012 May; 30 Suppl 2():B40-5. PubMed ID: 22607898 [TBL] [Abstract][Full Text] [Related]
18. Meningococcal meningitis: vaccination outbreak response and epidemiological changes in the African meningitis belt. Carod Artal FJ Int Health; 2015 Jul; 7(4):226-7. PubMed ID: 25878213 [TBL] [Abstract][Full Text] [Related]
19. Costs and impact of meningitis epidemics for the public health system in Burkina Faso. Colombini A; Badolo O; Gessner BD; Jaillard P; Seini E; Da Silva A Vaccine; 2011 Jul; 29(33):5474-80. PubMed ID: 21641952 [TBL] [Abstract][Full Text] [Related]